Merck & Co Q3 EPS $1.51 Beats $1.24 Estimate, Sales $12.397B Beat $11.63B Estimate

Merck & Co (NYSE:MRK) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $1.24 by 21.77 percent. This is a 26.89 percent increase over earnings of $1.19 per share from the same

Benzinga · 11/06/2019 13:32

Merck & Co (NYSE:MRK) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $1.24 by 21.77 percent. This is a 26.89 percent increase over earnings of $1.19 per share from the same period last year. The company reported quarterly sales of $12.397 billion which beat the analyst consensus estimate of $11.63 billion by 6.60 percent. This is a 14.85 percent increase over sales of $10.794 billion the same period last year.